STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
NBRV NABRIVA THERAPEUTICS PLC StockScouter® Report
8
StockScouter® Score
NABRIVA THERAPEUTICS PLC, a micro cap value company in the healthcare sector, is expected to outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
- The multi-period measure of relative price change and consistency is above average. Positive/Neutral
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
Concerns
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be in favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
A
B